104 related articles for article (PubMed ID: 16780094)
1. [Quality of life as an independent prognostic factor in advanced non-small-cell lung cancer in general practice].
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Noma S; Iwaki M; Aso H; Sakamoto K; Shimizu J
Nihon Kokyuki Gakkai Zasshi; 2006 May; 44(5):368-73. PubMed ID: 16780094
[TBL] [Abstract][Full Text] [Related]
2. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
[TBL] [Abstract][Full Text] [Related]
3. Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer.
Kaptein AA; Yamaoka K; Snoei L; Kobayashi K; Uchida Y; van der Kloot WA; Tabei T; Kleijn WC; Koster M; Wijnands G; Kaajan H; Tran T; Inoue K; van Klink R; van Dooren-Coppens E; Dik H; Hayashi F; Willems L; Annema-Schmidt D; Annema J; van der Maat B; van Kralingen K; Meirink C; Ogoshi K; Aaronson N; Nortier H; Rabe K
Lung Cancer; 2011 Jun; 72(3):384-90. PubMed ID: 20947200
[TBL] [Abstract][Full Text] [Related]
4. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
[TBL] [Abstract][Full Text] [Related]
5. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
Bezjak A; Tu D; Seymour L; Clark G; Trajkovic A; Zukin M; Ayoub J; Lago S; de Albuquerque Ribeiro R; Gerogianni A; Cyjon A; Noble J; Laberge F; Chan RT; Fenton D; von Pawel J; Reck M; Shepherd FA;
J Clin Oncol; 2006 Aug; 24(24):3831-7. PubMed ID: 16921034
[TBL] [Abstract][Full Text] [Related]
6. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
Ozturk A; Sarihan S; Ercan I; Karadag M
Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
[TBL] [Abstract][Full Text] [Related]
7. Association between changes in quality of life scores and survival in non-small cell lung cancer patients.
Gupta D; Braun DP; Staren ED
Eur J Cancer Care (Engl); 2012 Sep; 21(5):614-22. PubMed ID: 22309434
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.
Mu XL; Li LY; Zhang XT; Wang SL; Wang MZ
BMC Cancer; 2004 Aug; 4():51. PubMed ID: 15318946
[TBL] [Abstract][Full Text] [Related]
9. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528
[TBL] [Abstract][Full Text] [Related]
10. The effect of smoking cessation on quality of life after lung cancer surgery.
Balduyck B; Sardari Nia P; Cogen A; Dockx Y; Lauwers P; Hendriks J; Van Schil P
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1432-7; discussion 1437-8. PubMed ID: 21498082
[TBL] [Abstract][Full Text] [Related]
11. Measuring quality of life: an emerging science.
Moinpour CM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):48-60; discussion 60-3. PubMed ID: 7973770
[TBL] [Abstract][Full Text] [Related]
12. [Quality of life of long-term survivors of surgically treated lung cancer].
Nonaka M; Ohno M; Fukuzumi M; Shiojiri Y; Kataoka D; Yamamoto S; Asano M; Ohtake H; Tedoriya T; Kadokura M
Kyobu Geka; 2006 Jul; 59(7):519-28; discussion 528-30. PubMed ID: 16856525
[TBL] [Abstract][Full Text] [Related]
13. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
[TBL] [Abstract][Full Text] [Related]
14. Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors.
LoRusso PM; Herbst RS; Rischin D; Ranson M; Calvert H; Raymond E; Kieback D; Kaye S; Gianni L; Harris A; Bjork T; Maddox AM; Rothenberg ML; Small EJ; Rubin EH; Feyereislova A; Heyes A; Averbuch SD; Ochs J; Baselga J
Clin Cancer Res; 2003 Jun; 9(6):2040-8. PubMed ID: 12796366
[TBL] [Abstract][Full Text] [Related]
15. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials.
Hallqvist A; Bergman B; Nyman J
Radiother Oncol; 2012 Jul; 104(1):39-44. PubMed ID: 22727262
[TBL] [Abstract][Full Text] [Related]
16. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
18. Closeness to death and quality of life in advanced lung cancer patients.
Brown S; Thorpe H; Napp V; Brown J
Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):341-8. PubMed ID: 17379489
[TBL] [Abstract][Full Text] [Related]
19. Preoperative psychological global well being index (PGWBI) predicts postoperative quality of life for patients with non-small cell lung cancer managed with thoracic surgery.
Barlési F; Doddoli C; Loundou A; Pillet E; Thomas P; Auquier P
Eur J Cardiothorac Surg; 2006 Sep; 30(3):548-53. PubMed ID: 16860566
[TBL] [Abstract][Full Text] [Related]
20. Prospective external convergence evaluation of two different quality-of-life instruments in lung resection patients.
Pompili C; Brunelli A; Xiumé F; Refai M; Salati M; Socci L; Di Nunzio L; Sabbatini A
Eur J Cardiothorac Surg; 2011 Jul; 40(1):99-105. PubMed ID: 21159520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
